• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Unbearable Thrombus of COVID-19: Primary PCI, Thrombus, and COVID-19.

作者信息

Dauerman Harold L

机构信息

University of Vermont Larner College of Medicine, Burlington, Vermont.

出版信息

J Am Coll Cardiol. 2020 Sep 8;76(10):1177-1180. doi: 10.1016/j.jacc.2020.07.027.

DOI:10.1016/j.jacc.2020.07.027
PMID:32883410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7458532/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20c/7458532/95015ada2e1c/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20c/7458532/95015ada2e1c/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a20c/7458532/95015ada2e1c/fx1_lrg.jpg

相似文献

1
The Unbearable Thrombus of COVID-19: Primary PCI, Thrombus, and COVID-19.新冠疫情中难以承受的血栓：直接经皮冠状动脉介入治疗、血栓与新冠疫情
J Am Coll Cardiol. 2020 Sep 8;76(10):1177-1180. doi: 10.1016/j.jacc.2020.07.027.
2
Delay, Death, and Heterogeneity of Primary PCI During the COVID-19 Pandemic: An International Perspective.新冠疫情期间直接经皮冠状动脉介入治疗的延迟、死亡及异质性：国际视角
J Am Coll Cardiol. 2020 Nov 17;76(20):2331-2333. doi: 10.1016/j.jacc.2020.09.596.
3
Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report.COVID-19 患者肺移植术后合并 ST 段抬高型心肌梗死行直接经皮冠状动脉介入治疗：1 例报告。
J Zhejiang Univ Sci B. 2020 May;21(5):411-415. doi: 10.1631/jzus.B2000182. Epub 2020 May 9.
4
COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China.中国治疗ST段抬高型心肌梗死的COVID-19特异性策略。
J Am Coll Cardiol. 2020 Sep 15;76(11):1325-1327. doi: 10.1016/j.jacc.2020.07.054. Epub 2020 Aug 14.
5
Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.2019冠状病毒病大流行期间ST段抬高型心肌梗死的治疗
Cardiovasc Revasc Med. 2020 Aug;21(8):1024-1029. doi: 10.1016/j.carrev.2020.05.027. Epub 2020 May 21.
6
Multiple spontaneous coronary thrombosis causing ST-elevation myocardial infarction in a patient with COVID-19.一名新冠肺炎患者发生多次自发性冠状动脉血栓形成，导致ST段抬高型心肌梗死。
Br J Hosp Med (Lond). 2020 Jul 2;81(7):1-6. doi: 10.12968/hmed.2020.0337. Epub 2020 Jul 13.
7
COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems.新冠疫情与梗死：再次呼吁重组我们的医疗体系。
Heart. 2020 Dec;106(23):1786-1787. doi: 10.1136/heartjnl-2020-317981. Epub 2020 Oct 21.
8
Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?新冠疫情时代ST段抬高型心肌梗死的再灌注治疗：一切照旧？
Circulation. 2020 Jun 16;141(24):1948-1950. doi: 10.1161/CIRCULATIONAHA.120.047122. Epub 2020 Apr 13.
9
ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.ST段抬高型心肌梗死的治疗与COVID-19：溶栓治疗和药物介入策略的价值主张
Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006834. doi: 10.1161/CIRCOUTCOMES.120.006834. Epub 2020 Apr 27.
10
Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.为何在新冠疫情期间，ST段抬高型心肌梗死的纤溶治疗并非你新的最佳选择。
Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006885. doi: 10.1161/CIRCOUTCOMES.120.006885. Epub 2020 Apr 27.

引用本文的文献

1
ST-Segment Elevation Myocardial Infarction (STEMI) Management in the Era of COVID-19: A Systematic and Critical Review of Published Guidance Reports.2019冠状病毒病时代ST段抬高型心肌梗死（STEMI）的管理：对已发表指南报告的系统和批判性综述
Rev Cardiovasc Med. 2023 Feb 6;24(2):54. doi: 10.31083/j.rcm2402054. eCollection 2023 Feb.
2
Acute thrombotic occlusion involving three coronary arteries. A unique association with COVID-19 pneumonia.累及三支冠状动脉的急性血栓闭塞。与新冠肺炎的一种独特关联。
Clin Case Rep. 2023 Aug 15;11(8):e7803. doi: 10.1002/ccr3.7803. eCollection 2023 Aug.
3
The Clot Thickens: COVID-19-Related ST-Elevation Myocardial Infarction in the Setting of Recent Boosters.

本文引用的文献

1
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.COVID-19 患者中 ST 段抬高型心肌梗死血栓负荷高。
J Am Coll Cardiol. 2020 Sep 8;76(10):1168-1176. doi: 10.1016/j.jacc.2020.07.022. Epub 2020 Jul 14.
2
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.2019冠状病毒病（COVID-19）患者与流感患者发生缺血性卒中的风险比较
JAMA Neurol. 2020 Jul 2;77(11):1-7. doi: 10.1001/jamaneurol.2020.2730.
3
Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.
血栓形成：近期接种加强针情况下与新冠病毒相关的ST段抬高型心肌梗死
Cureus. 2023 Mar 28;15(3):e36814. doi: 10.7759/cureus.36814. eCollection 2023 Mar.
4
Myocardial infarction in times of COVID-19.新冠疫情期间的心肌梗死
Rev Esp Cardiol (Engl Ed). 2020 Dec;73(12):975-977. doi: 10.1016/j.rec.2020.09.023. Epub 2020 Oct 31.
5
Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection.血管紧张素转换酶 2 和周细胞在 COVID-19 感染心脏并发症中的作用。
Am J Physiol Heart Circ Physiol. 2020 Nov 1;319(5):H1059-H1068. doi: 10.1152/ajpheart.00681.2020. Epub 2020 Oct 9.
6
[Myocardial infarction in times of COVID-19].[新冠疫情期间的心肌梗死]
Rev Esp Cardiol. 2020 Dec;73(12):975-977. doi: 10.1016/j.recesp.2020.09.022. Epub 2020 Sep 30.
2019年冠状病毒病大流行对ST段抬高型心肌梗死表现及院内结局的影响
Circ Cardiovasc Interv. 2020 Jul;13(7):e009438. doi: 10.1161/CIRCINTERVENTIONS.120.009438.
4
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.新冠病毒肺炎住院患者治疗剂量抗凝与院内生存的相关性
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.
5
Multivessel coronary thrombosis in a patient with COVID-19 pneumonia.一名新冠肺炎患者出现多支冠状动脉血栓形成。
Eur Heart J. 2020 Jun 7;41(22):2132. doi: 10.1093/eurheartj/ehaa393.
6
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes.新型冠状病毒肺炎患者的ST段抬高型心肌梗死：临床及血管造影结果
Circulation. 2020 Jun 23;141(25):2113-2116. doi: 10.1161/CIRCULATIONAHA.120.047525. Epub 2020 Apr 30.
7
Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).《COVID-19 大流行期间急性心肌梗死的管理：心血管血管造影和介入学会（SCAI）、美国心脏病学会（ACC）和美国急诊医师学会（ACEP）的立场声明》
J Am Coll Cardiol. 2020 Sep 15;76(11):1375-1384. doi: 10.1016/j.jacc.2020.04.039. Epub 2020 Apr 21.
8
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
9
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态：血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
10
ST-Segment Elevation in Patients with Covid-19 - A Case Series.新型冠状病毒肺炎患者的ST段抬高——病例系列
N Engl J Med. 2020 Jun 18;382(25):2478-2480. doi: 10.1056/NEJMc2009020. Epub 2020 Apr 17.